CompletedPhase 4

Fuchs' Torsional Phaco Study

Netherlands50 participantsStarted 2008-12

Plain-language summary

The primary objective is to compare the effect of torsional phacoemulsification and longitudinal phacoemulsification on central and peripheral corneal thickness/volume after cataract surgery in patients with Fuchs' endothelial dystrophy.

Who can participate

Age range40 Years – 95 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients diagnosed with Fuchs' endothelial dystrophy (all stages) and planning to undergo cataract surgery due to visually significant cataract * Patients should be 40 years of age or older Exclusion Criteria: * Patients with Fuchs' dystrophy with a history of previous corneal or intraocular surgery * Patients with a planned combined surgical procedure * Patients who have other vision-affecting disorders than Fuchs' endothelial dystrophy

What they're measuring

Change in central corneal thickness/corneal volume

Timeframe: 1, 7 days and 1 , 3 and 6 months postoperatively

Trial details

NCT IDNCT00781027

SponsorMaastricht University Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-05

View on ClinicalTrials.gov More Fuchs' Endothelial Dystrophy trials